デフォルト表紙
市場調査レポート
商品コード
1421659

パレステジア(異常感覚)治療市場、シェア、規模、動向、産業分析レポート:タイプ別、治療別、エンドユーザー別、地域別、セグメント別予測、2023年~2032年

Paresthesia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Acute Paresthesia, Chronic Paresthesia); By Treatment; By End-User; By Region; Segment Forecast, 2023 - 2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
パレステジア(異常感覚)治療市場、シェア、規模、動向、産業分析レポート:タイプ別、治療別、エンドユーザー別、地域別、セグメント別予測、2023年~2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、パレステジア(異常感覚)療の世界市場規模は2032年までに82億6,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

パレステジア(異常感覚)の治療や診断を含む高度なヘルスケアサービスへのアクセス拡大を可能にする世界中のヘルスケア支出の急激な増加や、炎症や神経損傷などのパレステジア(異常感覚)の根本的な原因を標的とした薬剤の市場開拓への投資の増加は、世界市場の成長を促進する顕著な要因です。加えて、パレステジア(異常感覚)とその利用可能な治療オプションに関するヘルスケア専門家と一般市民の意識の高まりは、早期診断と早期介入につながり、市場の成長を加速させる可能性が高いです。

例えば、2023年に発表された報告書によると、インドの保健・家族福祉省は、2023-24年度連邦予算で約110億米ドルの割り当てを受けたと発表しており、前年度予算と比較して約12.6%増加しています。

さらに、経皮的電気神経刺激や経頭蓋磁気刺激など、非侵襲的な神経調節法に焦点を当てた技術革新の数が大幅に増加しています。これらの技術は主に、外科的移植を必要とせずにより良い救済を提供することを目的としているため、近い将来、市場に巨大な収益機会を生み出すことになります。

近年、遺伝子治療や幹細胞治療のような先進的な治療法が急速に開拓され、個々の患者に合わせた治療を効率的に行うため、遺伝子、分子、臨床データに基づく個別化治療法の開発に注目が集まっています。

また、理学療法、作業療法、心理学的サポートなど、さまざまな補完療法を知覚麻痺の治療計画に統合する動きが広まっており、知覚麻痺のさまざまな側面に対処しながら、患者全体の転帰を改善する可能性と能力があることから、今後数年間で市場にプラスの影響を与える可能性が高いです。

パレステジア(異常感覚)治療市場レポート・ハイライト

  • 慢性知覚麻痺治療薬が最大シェアを占める。
  • 抗けいれん薬部門が市場シェアの大半を占めたが、これは神経因性疼痛の管理に広く使用されていることと、その高い安全性プロファイルによるところが大きいです。
  • 診断センター分野は、革新的な治療機器が利用可能であることから診断センターの人気が高まっており、最も速いペースで成長すると思われます。
  • 北米はヘルスケアインフラが発達しており、様々な慢性疾患が蔓延していることから、世界市場を席巻しています。
  • 主な市場参入企業は、ボストン・サイエンティフィック、オムロンヘルスケア、メドトロニック、バクスター・インターナショナル、アボット・ラボラトリーズ、バイオメディカル・リサーチなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のパレステジア(異常感覚)治療市場に関する洞察

  • 感覚異常治療市場- エンドユーザーのスナップショット
  • 感覚異常治療市場力学
    • 促進要因と機会
      • 世界中で神経疾患の発生率が増加し、世界市場の成長を牽引
      • 新しい治療法や医薬品の開発
    • 抑制要因と課題
      • 高額な治療費
  • PESTEL分析
  • パレステジア(異常感覚)治療市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のパレステジア(異常感覚)治療市場、治療別

  • 主な調査結果
  • イントロダクション
  • 免疫抑制剤
  • 抗けいれん薬
  • 局所クリーム
  • 抗ウイルス薬

第6章 世界のパレステジア(異常感覚)治療市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 急性パレステジア
  • 慢性パレステジア

第7章 世界のパレステジア(異常感覚)治療市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • 診断センター

第8章 世界のパレステジア(異常感覚)治療市場、地域別

  • 主な調査結果
  • イントロダクション
    • パレステジア(異常感覚)治療市場評価、地域、2019-2032年
  • 感覚異常治療市場-北米
    • 北米:パレステジア(異常感覚)治療市場、治療別、2019-2032年
    • 北米:パレステジア(異常感覚)治療市場、エンドユーザー別、2019~2032年
    • 北米:パレステジア(異常感覚)治療市場、タイプ別、2019-2032年
    • 感覚異常治療市場-米国
    • 感覚異常治療市場- カナダ
  • 感覚異常治療市場- 欧州
    • 欧州:パレステジア(異常感覚)治療市場、治療別、2019~2032年
    • 欧州:パレステジア(異常感覚)治療市場、エンドユーザー別、2019~2032年
    • 欧州:パレステジア(異常感覚)治療市場、タイプ別、2019~2032年
    • 感覚異常治療市場- 英国
    • 感覚異常治療市場- フランス
    • 感覚異常治療市場- ドイツ
    • 感覚異常治療市場- イタリア
    • 感覚異常治療市場- スペイン
    • 感覚異常治療市場- オランダ
    • 感覚異常治療市場- ロシア
  • 感覚異常治療市場- アジア太平洋
    • アジア太平洋:パレステジア(異常感覚)治療市場、治療別、2019~2032年
    • アジア太平洋:パレステジア(異常感覚)治療市場、エンドユーザー別、2019~2032年
    • アジア太平洋:パレステジア(異常感覚)治療市場、タイプ別、2019~2032年
    • 感覚異常治療市場- 中国
    • 感覚異常治療市場- インド
    • 感覚異常治療市場- マレーシア
    • 感覚異常治療市場- 日本
    • 感覚異常治療市場- インドネシア
    • 感覚異常治療市場- 韓国
  • 感覚異常治療市場-中東およびアフリカ
    • 中東およびアフリカ:パレステジア(異常感覚)治療市場、治療別、2019~2032年
    • 中東およびアフリカ:パレステジア(異常感覚)治療市場、エンドユーザー別、2019~2032年
    • 中東およびアフリカ:パレステジア(異常感覚)治療市場、タイプ別、2019~2032年
    • 感覚異常治療市場- サウジアラビア
    • 感覚異常治療市場- アラブ首長国連邦
    • 感覚異常治療市場- イスラエル
    • 感覚異常治療市場- 南アフリカ
  • 感覚異常治療市場-ラテンアメリカ
    • ラテンアメリカ:パレステジア(異常感覚)治療市場、治療別、2019-2032年
    • ラテンアメリカ:パレステジア(異常感覚)治療市場、エンドユーザー別、2019~2032年
    • ラテンアメリカ:パレステジア(異常感覚)治療市場、タイプ別、2019~2032年
    • 感覚異常治療市場- メキシコ
    • 感覚異常治療市場- ブラジル
    • 感覚異常治療市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Laboratories
  • Baxter International Inc.
  • Bio-Medical Research Ltd.
  • Boston Scientific Corporation
  • Cipla Ltd.
  • ElectroCore LLC
  • EnteroMedics Inc.
  • Medtronic Plc
  • Nevro Corporation
  • Omron Healthcare Inc.
  • Pfizer
  • St. Jude Medical LLC
  • Stimwave LLC
  • Stryker Corporation
図表

List of Tables

  • Table 1 Global Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 2 Global Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Global Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 4 Paresthesia Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 6 North America: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 8 U.S.: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 9 U.S.: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 11 Canada: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 12 Canada: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 14 Europe: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 15 Europe: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 17 UK: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 18 UK: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 19 UK: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 20 France: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 21 France: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 22 France: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 23 Germany: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 24 Germany: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 26 Italy: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 27 Italy: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 29 Spain: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 30 Spain: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 35 Russia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 36 Russia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 41 China: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 42 China: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 43 China: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 44 India: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 45 India: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 46 India: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 50 Japan: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 51 Japan: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 56 South Korea: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 57 South Korea: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 65 UAE: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 66 UAE: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 68 Israel: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 69 Israel: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 71 South Africa: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 72 South Africa: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 74 Latin America: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 75 Latin America: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 77 Mexico: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 78 Mexico: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 80 Brazil: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 81 Brazil: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • Table 83 Argentina: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 84 Argentina: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Paresthesia Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Paresthesia Treatment Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Treatment
  • Figure 9. Global Paresthesia Treatment Market, by Treatment, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-User
  • Figure 11. Global Paresthesia Treatment Market, by End-User, 2022 & 2032 (USD Billion)
  • Figure 12. Paresthesia Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Paresthesia Treatment Market
目次
Product Code: PM3991

The global paresthesia treatment market size is expected to reach USD 8.26 billion by 2032, according to a new study by Polaris Market Research. The report "Paresthesia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Acute Paresthesia, Chronic Paresthesia); By Treatment; By End-User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The exponential rise in healthcare spending across the world that allows for greater access to advanced healthcare services including paresthesia treatment and diagnosis and growing investments in the development of drugs targeting the underlying causes of paresthesia such as inflammation and nerve damage, are prominent factors fostering the global market growth. In addition, the rising awareness among both healthcare professionals and general public about paresthesia and its available treatment options that leading to earlier diagnosis and intervention, are further likely to escalate market growth at rapid pace over the years.

For instance, as per a report published in 2023, Ministry of Health & Family Welfare, India, announced that they have received an allocation of approx. USD 11 billion in the Union budget 2023-24, with an increase of around 12.6 percent compared to the budget of previous year.

Furthermore, there is a significant increase in the number of innovations focusing on non-invasive methods of neuromodulation such as transcutaneous electrical nerve stimulation and transcranial magnetic stimulation, as these techniques mainly aim to provide better relief without needing any kind of surgical implantation, which in turn, generating huge revenue opportunities for the market in the near future.

In the recent years, the rapid development of new and more advanced treatments like gene therapy and stem cell therapy and growing focus on developing personalized treatment approaches based on the genetic, molecular, and clinical data in order to efficiently tailor therapies to individual patients and likely to cater to growing market needs.

With the growing proliferation for the integration of several types of complementary therapies such as physical therapy, occupational therapy, and psychological support, into paresthesia treatment plans due to its potential and ability to improve overall patient outcomes, while addressing the various dimensions of paresthesia, are also likely to have a positive impact on the market in the coming years.

Paresthesia Treatment Market Report Highlights

  • Chronic paresthesia segment accounted for largest share, on account of growing incidence of several types of chronic conditions worldwide
  • Anticonvulsants segment held the majority market share, that is largely attributed to widespread use to manage neuropathic pain and its higher safety profile
  • Diagnosis centers segment will grow at fastest pace, due to increasing popularity of diagnosis centers because of the availability of innovated treatment equipment
  • North America dominated the global market, owing to region's well-developed healthcare infrastructure a prevalence for various chronic conditions
  • The key market players include Boston Scientific, Omron Healthcare, Medtronic, Baxter International, Abbott Laboratories, and Bio-Medical Research

Polaris Market Research has segmented the paresthesia treatment market report based on type, treatment, end-user, and region:

Paresthesia Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acute Paresthesia
  • Chronic Paresthesia

Paresthesia Treatment, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

  • Immunosuppressants
  • Anticonvulsants
  • Topical Creams
  • Antivirals

Paresthesia Treatment, End-User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Clinics
  • Diagnosis Centers

Paresthesia Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Paresthesia Treatment Market Insights

  • 4.1. Paresthesia Treatment Market - End-User Snapshot
  • 4.2. Paresthesia Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidences of neurological illnesses worldwide driving the global market growth
      • 4.2.1.2. Development of novel therapies and pharmaceuticals
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Paresthesia Treatment Market End-User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Paresthesia Treatment Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 5.3. Immunosuppressants
    • 5.3.1. Global Paresthesia Treatment Market, by Immunosuppressants, by Region, 2019-2032 (USD Billion)
  • 5.4. Anticonvulsants
    • 5.4.1. Global Paresthesia Treatment Market, by Anticonvulsants, by Region, 2019-2032 (USD Billion)
  • 5.5. Topical Creams
    • 5.5.1. Global Paresthesia Treatment Market, by Topical Creams, by Region, 2019-2032 (USD Billion)
  • 5.6. Antivirals
    • 5.6.1. Global Paresthesia Treatment Market, by Antivirals, by Region, 2019-2032 (USD Billion)

6. Global Paresthesia Treatment Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Acute Paresthesia
    • 6.3.1. Global Paresthesia Treatment Market, by Acute Paresthesia, by Region, 2019-2032 (USD Billion)
  • 6.4. Chronic Paresthesia
    • 6.4.1. Global Paresthesia Treatment Market, by Chronic Paresthesia, by Region, 2019-2032 (USD Billion)

7. Global Paresthesia Treatment Market, by End-User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Paresthesia Treatment Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Clinics
    • 7.4.1. Global Paresthesia Treatment Market, by Clinics, By Region, 2019-2032 (USD Billion)
  • 7.5. Diagnosis Centers
    • 7.5.1. Global Paresthesia Treatment Market, by Diagnosis Centers, By Region, 2019-2032 (USD Billion)

8. Global Paresthesia Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Paresthesia Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Paresthesia Treatment Market - North America
    • 8.3.1. North America: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 8.3.2. North America: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
    • 8.3.3. North America: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4. Paresthesia Treatment Market - U.S.
      • 8.3.4.1. U.S.: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5. Paresthesia Treatment Market - Canada
      • 8.3.5.1. Canada: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.4. Paresthesia Treatment Market - Europe
    • 8.4.1. Europe: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4. Paresthesia Treatment Market - UK
      • 8.4.4.1. UK: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5. Paresthesia Treatment Market - France
      • 8.4.5.1. France: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6. Paresthesia Treatment Market - Germany
      • 8.4.6.1. Germany: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7. Paresthesia Treatment Market - Italy
      • 8.4.7.1. Italy: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8. Paresthesia Treatment Market - Spain
      • 8.4.8.1. Spain: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9. Paresthesia Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10. Paresthesia Treatment Market - Russia
      • 8.4.10.1. Russia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.5. Paresthesia Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4. Paresthesia Treatment Market - China
      • 8.5.4.1. China: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5. Paresthesia Treatment Market - India
      • 8.5.5.1. India: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6. Paresthesia Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7. Paresthesia Treatment Market - Japan
      • 8.5.7.1. Japan: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8. Paresthesia Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9. Paresthesia Treatment Market - South Korea
      • 8.5.9.1. South Korea: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.6. Paresthesia Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4. Paresthesia Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5. Paresthesia Treatment Market - UAE
      • 8.6.5.1. UAE: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6. Paresthesia Treatment Market - Israel
      • 8.6.6.1. Israel: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7. Paresthesia Treatment Market - South Africa
      • 8.6.7.1. South Africa: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
  • 8.7. Paresthesia Treatment Market - Latin America
    • 8.7.1. Latin America: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4. Paresthesia Treatment Market - Mexico
      • 8.7.4.1. Mexico: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5. Paresthesia Treatment Market - Brazil
      • 8.7.5.1. Brazil: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6. Paresthesia Treatment Market - Argentina
      • 8.7.6.1. Argentina: Paresthesia Treatment Market, by Treatment, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Paresthesia Treatment Market, by End-User, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Paresthesia Treatment Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Baxter International Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Medical Research Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Boston Scientific Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Cipla Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. ElectroCore LLC
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. EnteroMedics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medtronic Plc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Nevro Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Omron Healthcare Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. St. Jude Medical LLC
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Stimwave LLC
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Stryker Corporation
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development